|
2025
|
P/S
|
Pharmaceutical preparations for treating diabetes Pharmaceutical research and development Providi... |
|
2024
|
Invention
|
Novel combinations for antigen based therapy.
The present invention relates to a method for prev... |
|
2020
|
Invention
|
Preventing and treating hypoglycemia.
The present invention relates to Gamma-amino butyric acid,... |
|
|
Invention
|
Preventing and treating hypoglycemia. The present invention relates to Gamma-amino butyric acid, ... |
|
2019
|
Invention
|
Novel combinations for antigen based therapy.
Provided herein, among other things, is a method f... |
|
|
Invention
|
New use and methods of modulating immune responses.
The present invention relates to methods for... |
|
|
Invention
|
New use and methods of modulating immune responses. The present invention relates to methods for ... |
|
|
Invention
|
Gaba a receptor agonists for treatment of disorders influenced by dysfunction beta cells. A recep... |
|
|
Invention
|
Gaba a receptor agonists for treatment of disorders influenced by dysfunction beta cells. Ain vit... |
|
|
Invention
|
Novel composition and use thereof.
The present invention relates to the use of at least two auto... |
|
|
Invention
|
Novel composition and use thereof. The present invention relates to the use of at least two autoa... |
|
2018
|
Invention
|
Genotype stratification in diabetes treatment and prevention.
The present invention relates to a... |
|
|
Invention
|
Genotype stratification in diabetes treatment and prevention. The present invention relates to a ... |
|
|
Invention
|
Improved immunotherapy.
The invention relates to a method for assessing the efficacy of an immun... |
|
|
Invention
|
Improved immunotherapy. The invention relates to a method for assessing the efficacy of an immuno... |
|
|
Invention
|
Formulation of gamma-aminobutyric acid. The present invention relates to an oral dosage form comp... |
|
|
Invention
|
New formulation of gamma-aminobutyric acid. The present invention relates to an oral dosage form ... |
|
|
P/S
|
Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treat... |
|
|
P/S
|
Pharmaceutical preparations; Vaccines; excluding the diagnostics field. Research and development ... |
|
2017
|
P/S
|
Anti-diabetic pharmaceuticals all in the nature of pharmaceutical preparations for the prevention... |
|
|
P/S
|
Pharmaceutical preparations for treating diabetes |
|
2016
|
Invention
|
Combination therapy using gliadin and gamma aminobutyric acid.
The present invention relates to ... |
|
|
Invention
|
Combination therapy using gliadin and gamma aminobutyric acid. The present invention relates to t... |
|
|
Invention
|
New use.
The present invention relates to a method for in vitro cultivation of hematopoietic and... |
|
|
Invention
|
New use. The present invention relates to a method for in vitro cultivation of hematopoietic and/... |
|
2015
|
Invention
|
Novel combinations for antigen based therapy. The present invention relates to a method for preve... |
|
2009
|
Invention
|
Immunomodulation for autoimmune type-2 diabetes.
The present invention regards methods and formu... |
|
2006
|
Invention
|
Formulation of antigen.
The present invention regards methods and formulations for diagnosis, pr... |
|
2005
|
Invention
|
Gad2 gene for possible treatment of nervous system disorders. The present invention regards metho... |
|
|
Invention
|
Formulation of glutamic acid decarboxylase (gad65) and serum albumin. The present application dea... |
|
|
Invention
|
Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of... |
|
2003
|
Invention
|
Formulation of glutarmic acid decarboxylase (gad65) and serum albumin. The present invention rega... |
|
1997
|
Invention
|
Method and a system for determination of components of a substance. A method and system for deter... |
|
1995
|
Invention
|
Methods and kits useful for determining the status of and detecting pancreatic b-cell associated ... |
